## 3 Results
\begin{table}
\begin{tabular}{c c c c c c} \hline \hline  & **Drug-Taken** & **N (\%)** & \multicolumn{4}{c}{**Stratified by Age n (\%)**} \\ \cline{3-6}  & **0-14** & **15-64** & \(\geq\)**65** & \(p\) **Value** \\ \hline \multicolumn{6}{c}{Pattern length = 1} \\ \multicolumn{6}{c}{Disease patterns:} \\ \hline \(<\)(f)\(>\) Respiratory system & 51 & 34 (66.67) & 14 (27.45) & 3 (5.88) & * 0.000 \\ \hline \(<\)(f)\(>\) & 32 (62.75) & 23 (71.88) & 8 (25.00) & 1 (3.13) & * 0.000 \\ \(<\)(f)\(>\) & 9 (17.65) & 6 (66.67) & 2 (22.22) & 1 (11.11) & 0.166 \\ \(<\)(f)\(>\) & 6 (11.76) & 5 (83.33) & 1 (16.67) & & NC \\ \hline \(<\)(12)\(>\) Skin and subcutaneous tissue & 30 & 11 (36.67) & 12 (40.00) & 7 (23.33) & 0.594 \\ \hline \(<\)(f)\(>\) & 11 (36.67) & 2 (18.18) & 7 (63.64) & 2 (18.18) & 0.134 \\ \(<\)(f)\(>\) & 7 (23.33) & 2 (28.57) & 2 (28.57) & 3 (42.86) & 1 \\ \(<\)(f)\(>\) & 6 (20.00) & 4 (66.67) & 2 (33.33) & NC \\ \(<\)(f)\(>\) & 5 (16.66) & 2 (40.00) & 3 (60.00) & NC \\ \(<\)(f)\(>\) & 4 (13.33) & 3 (75.00) & 1 (25.00) & NC \\ \(<\)(f)\(>\) & 4 (13.33) & 2 (50.00) & 2 (50.00) & NC \\ \(<\)(f U)\(>\) & 3 (10.00) & & 2 (66.67) & 1 (33.33) & NC \\ \hline \(<\)(16)\(>\) Symptoms, signs, and ill-defined conditions & 23 & 10 (43.48) & 7 (30.43) & 6 (26.09) & 0.654 \\ \hline \(<\)(f)\(>\) & 16 (69.57) & 7 (43.75) & 6 (37.5) & 3 (18.75) & 0.541 \\ \(<\)(U)\(>\) & 4 (17.39) & 1 (25.00) & & 3 (75.00) & NC \\ \hline \(<\)(f)\(>\) Digestive system & 17 & 5 (29.41) & 7 (41.18) & 5 (29.41) & 0.867 \\ \hline \(<\)(f)\(>\) & 9 (52.94) & 2 (22.22) & 5 (55.56) & 2 (22.22) & 0.531 \\ \(<\)(f)\(>\) & 3 (17.65) & & 3 (100.00) & & NC \\ \(<\)(f)\(>\) & 2 (11.76) & & 1 (50.00) & 1 (50.00) & NC \\ \(<\)(f)\(>\) & 2 (11.76) & 1 (50.00) & 1 (50.00) & NC \\ \(<\)(f)\(>\) & 2 (11.76) & 1 (50.00) & 1 (50.00) & NC \\ \(<\)(f)\(>\) & 2 (11.76) & & 1 (50.00) & 1 (50.00) & NC \\ \hline \(<\)(f)\(>\) Circulatory system & 15 & 6 (40.00) & 9 (60.00) & NC \\ \hline \(<\)(f)\(>\) & 9 (60.00) & & 1 (11.11) & 8 (88.89) & NC \\ \(<\)(f)\(>\) & 8 (53.33) & 4 (50.00) & 4 (50.00) & NC \\ \(<\)(f)\(>\) & 4 (65.67) & & 4 (100.00) & NC \\ \(<\)(f)\(>\) & 3 (20.00) & & 2 (66.67) & 1(33.33) & NC \\ \(<\)(f)\(>\) & 2 (13.33) & 2 (100.00) & NC \\ \hline \(<\)(f)\(>\) Nervous system and sense organs & 14 & 3 (21.43) & 7 (50.00) & 4 (28.57) & 0.499 \\ \hline \(<\)(f)\(>\) & 6 (42.86) & 1 (16.67) & 4 (66.67) & 1 (16.67) & 0.383 \\ \(<\)(f)\(>\) & 6 (42.86) & 1 (16.67) & 2 (33.33) & 3 (50.00) & 0.877 \\ \(<\)(f)\(>\) & 3 (21.43) & 3 (100.00) & NC \\ \(<\)(f U)\(>\) & 2 (14.29) & & 3 (100.00) & NC \\ \hline \multicolumn{6}{c}{Pattern length = 2} \\ \multicolumn{6}{c}{Disease patterns:} \\ \hline \(<\)(8) (8) (8)\(>\) Respiratory system & 23 & 16 (69.57) & 6 (26.09) & 1 (4.35) & * 0.000 \\ \hline \(<\)(f) (T)\(>\) & 13 (56.52) & 10 (76.92) & 3 (23.08) & NC \\ \(<\)(U) (T)\(>\) & 4 (17.39) & 3 (75.00) & 1 (25.00) & NC \\ \(<\)(f U) (T)\(>\) & 3 (13.04) & 2 (66.67) & 1 (33.33) & NC \\ \hline \(<\)(8) (12)\(>\) Respiratory system, Skin and subcutaneous tissue & 14 & 12 (85.71) & 2 (14.29) & NC \\ \hline \(<\)(f) (T)\(>\) & 5 (35.71) & 5 (100.00) & & NC \\ \(<\)(f) (D)\(>\) & 3 (21.43) & 2 (66.67) & 1 (33.33) & NC \\ \hline \multicolumn{6}{c}{Pattern length = 3} \\ \multicolumn{6}{c}{Disease pattern:} \\ \hline \(<\)(8) (8) (8) (8)\(>\) Respiratory system & 14 & 12 (85.71) & 2 (14.29) & NC \\ \hline \(<\)(f) (T) (T)\(>\) & 7 (50.00) & 7 (100.00) & & NC \\ \(<\)(f) (H) (H)\(>\) & 2 (15.38) & 2 (100.00) & & NC \\ \hline \multicolumn{6}{c}{Pattern length = 4} \\ \multicolumn{6}{c}{Disease pattern:} \\ \hline \(<\)(8) (8) (8) (8)\(>\) Respiratory system & 13 & 11 (84.62) & 2 (15.38) & NC \\ \hline \(<\)(f) (T) (T) (T)\(>\) & 3 (23.08) & 3 (100.00) & NC \\ \(<\)(f)(H) (H) (H)\(>\) & 2 (15.38) & 2 (100.00) & & NC \\ \hline \(<\)(f) (T) (T)\(>\)Six disease patterns were found in the length 1 group. Examination of these drug patterns revealed NSAIDs (T) in every disease pattern, and it was the medication with the highest frequency for most disease patterns.